chr1-86352927-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366781.1(ODF2L):c.1738T>A(p.Leu580Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,546,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001366781.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ODF2L | NM_001366781.1 | c.1738T>A | p.Leu580Ile | missense_variant | 16/17 | ENST00000460698.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ODF2L | ENST00000460698.7 | c.1738T>A | p.Leu580Ile | missense_variant | 16/17 | 5 | NM_001366781.1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152150Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000955 AC: 23AN: 240822Hom.: 0 AF XY: 0.0000614 AC XY: 8AN XY: 130226
GnomAD4 exome AF: 0.000118 AC: 164AN: 1394090Hom.: 0 Cov.: 24 AF XY: 0.000126 AC XY: 88AN XY: 696666
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152150Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 31, 2023 | The c.1825T>A (p.L609I) alteration is located in exon 17 (coding exon 16) of the ODF2L gene. This alteration results from a T to A substitution at nucleotide position 1825, causing the leucine (L) at amino acid position 609 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at